Literature DB >> 2970248

Differential cognitive impairment in Alzheimer's disease and Huntington's disease.

J Brandt1, S E Folstein, M F Folstein.   

Abstract

The differentiation between cortical and subcortical dementias requires that the cognitive characteristics of dementias attributable to different causes be discriminable. For large samples of Alzheimer's disease and Huntington's disease patients, distinct cognitive profiles were obtained on the Mini-Mental State Exam. The profile differences were independent of severity of dementia and were sufficiently robust to classify patients as Alzheimer's disease or Huntington's disease with 84% accuracy. The qualitative differences in cognitive functioning may also be typical of other cortical and subcortical dementias.

Entities:  

Mesh：

Year:  1988        PMID： 2970248     DOI： 10.1002/ana.410230605

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


  28 in total

1.  Auditory confrontation naming in Alzheimer's disease.

Authors:  Jason Brandt; Arnold Bakker; David Aaron Maroof
Journal:  Clin Neuropsychol       Date:  2010-10-27       Impact factor: 3.535

2.  Combinations of Chronic Conditions, Functional Limitations, and Geriatric Syndromes that Predict Health Outcomes.

Authors:  Siran M Koroukian; Nicholas Schiltz; David F Warner; Jiayang Sun; Paul M Bakaki; Kathleen A Smyth; Kurt C Stange; Charles W Given
Journal:  J Gen Intern Med       Date:  2016-02-22       Impact factor: 5.128

3.  Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease.

Authors:  S Palfi; R J Ferrante; E Brouillet; M F Beal; R Dolan; M C Guyot; M Peschanski; P Hantraye
Journal:  J Neurosci       Date:  1996-05-01       Impact factor: 6.167

4.  Behavioral Changes in Huntington Disease

Authors:  Jason Brandt
Journal:  Cogn Behav Neurol       Date:  2018-03       Impact factor: 1.600

5.  Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.

Authors:  S E Starkstein; L Sabe; G Petracca; E Chemerinski; G Kuzis; M Merello; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

6.  Neocortical neurotransmitter markers in Huntington's disease.

Authors:  S J Pearson; G P Reynolds
Journal:  J Neural Transm Gen Sect       Date:  1994

7.  The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.

Authors:  D M Mann; R Oliver; J S Snowden
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Use of the frontal assessment battery in evaluating executive dysfunction in patients with Huntington's disease.

Authors:  Guilherme Riccioppo Rodrigues; Carolina Pinto Souza; Roberto Satler Cetlin; Daniel Sabino de Oliveira; Marcio Pena-Pereira; Liliana Tiemi Ujikawa; Wilson Marques; Vitor Tumas
Journal:  J Neurol       Date:  2009-06-18       Impact factor: 4.849

Review 9.  [Functional imaging of cognitive processes in Huntington's disease and its presymptomatic mutation carriers].

Authors:  R C Wolf; N Vasic; C Schönfeldt-Lecuona; D Ecker; G B Landwehrmeyer
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

10.  Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls.

Authors:  M T T Silva; P Mattos; A Alfano; A Q-C Araújo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.